TOVX

Theriva Biologics Inc

$0.22

-0.02 (-9.56%)

Analyst Overview

Target Price:

Date: 10.01.2026

$7.00

(+3090.52%)

Strong Buy: 0

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

Description:

Theriva Biologics Inc. (TOVX) is a clinical-stage biotechnology company based in Rockville, Maryland, dedicated to addressing significant unmet medical needs through the development of innovative biologic therapies. Utilizing its proprietary technology platforms, Theriva is focused on creating targeted treatment solutions that enhance patient outcomes across various therapeutic areas. With a robust pipeline and an experienced management team, the company is well-equipped to advance its promising candidates, positioning itself as a key player in the evolving healthcare landscape.

Exchange:

NYSE MKT

Country:

USA

Sector:

HEALTHCARE

Industry:

BIOTECHNOLOGY

Address:

9605 MEDICAL CENTER DRIVE, ROCKVILLE, MD, UNITED STATES, 20850

Fiscal year end:

December

Market capitalization:

$7.83 Million

EBITDA:

-$16.5 Million

PERatio:

0.106

EPS:

2.06

Dividend per share:

$0.00

Dividend yield:

0.0%

Beta:

0.344

Dividends for 10 years

Income Statements for 10 years

Earnings calender

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:

$1,000

How much will you earn in 10 years:

-100%

How much will you get:

Prices dates:

31-12-2015: $20,037.50 and 31-12-2025: $0.21